Your Gateway to World-Class Healthcare in India
Comprehensive leukemia care with advanced protocols, targeted therapies, and stem cell transplantation by experienced hematologists and oncologists.
Leukemia is a cancer of blood-forming tissues, including bone marrow and lymphatic system. India offers world-class leukemia treatment with advanced protocols, targeted therapies, and comprehensive supportive care at significantly lower costs than Western countries.
Our hematology centers provide personalized treatment plans based on leukemia type, genetic markers, and patient factors. With access to latest therapies including CAR T-cell therapy and clinical trials, patients receive cutting-edge care.
Fast-growing cancer of lymphoid cells
Fast-growing cancer of myeloid cells
Slow-growing cancer of lymphoid cells
Slow-growing cancer with BCR-ABL gene
$400,000
Average treatment cost
$250,000
Average treatment cost
$300,000
Average treatment cost
$25,000
Save 80%!
A. Success rates vary by type: ALL in children has 85% cure rate, AML has 60-70% remission rate, and CML has 95% 10-year survival with targeted therapy.
A. Treatment duration varies: acute leukemias require 6-8 months of intensive treatment, while chronic leukemias may need long-term management.
A. Not all patients need transplant. It's typically reserved for high-risk cases, relapsed disease, or when initial treatment fails.
A. Common side effects include fatigue, infection risk, bleeding, nausea, hair loss, and organ toxicity. Modern supportive care minimizes these effects.
Get personalized treatment information and cost estimates